WATCH: At Davos, industry leaders discuss the promise and pitfalls of precision medicine

There’s endless talk about precision medicine. But what’s really moving the needle — and what’s limiting its potential— now and in the future?

Those were the questions that brought together a handful of high-profile names in biopharma for a panel discussion on Friday at the final day of the World Economic Forum’s annual meeting in the Swiss resort town of Davos.